These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25591598)

  • 1. Assessing the interactions between the associations of common genetic variants on 2q35 and 16q12 with breast cancer risk.
    Fan YL; Guo ZJ; Zhu P; Yang XJ; Yang XD; Yu B; Li LH
    Neoplasma; 2015; 62(2):315-25. PubMed ID: 25591598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.
    Gu C; Zhou L; Yu J
    PLoS One; 2013; 8(7):e66979. PubMed ID: 23894282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
    Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J
    PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
    Broeks A; Schmidt MK; Sherman ME; Couch FJ; Hopper JL; Dite GS; Apicella C; Smith LD; Hammet F; Southey MC; Van 't Veer LJ; de Groot R; Smit VT; Fasching PA; Beckmann MW; Jud S; Ekici AB; Hartmann A; Hein A; Schulz-Wendtland R; Burwinkel B; Marme F; Schneeweiss A; Sinn HP; Sohn C; Tchatchou S; Bojesen SE; Nordestgaard BG; Flyger H; Ørsted DD; Kaur-Knudsen D; Milne RL; Pérez JI; Zamora P; Rodríguez PM; Benítez J; Brauch H; Justenhoven C; Ko YD; ; Hamann U; Fischer HP; Brüning T; Pesch B; Chang-Claude J; Wang-Gohrke S; Bremer M; Karstens JH; Hillemanns P; Dörk T; Nevanlinna HA; Heikkinen T; Heikkilä P; Blomqvist C; Aittomäki K; Aaltonen K; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Kauppinen JM; Kataja V; Auvinen P; Eskelinen M; Soini Y; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; Holland H; ; ; Lambrechts D; Claes B; Vandorpe T; Neven P; Wildiers H; Flesch-Janys D; Hein R; Löning T; Kosel M; Fredericksen ZS; Wang X; Giles GG; Baglietto L; Severi G; McLean C; Haiman CA; Henderson BE; Le Marchand L; Kolonel LN; Alnæs GG; Kristensen V; Børresen-Dale AL; Hunter DJ; Hankinson SE; Andrulis IL; Mulligan AM; O'Malley FP; Devilee P; Huijts PE; Tollenaar RA; Van Asperen CJ; Seynaeve CS; Chanock SJ; Lissowska J; Brinton L; Peplonska B; Figueroa J; Yang XR; Hooning MJ; Hollestelle A; Oldenburg RA; Jager A; Kriege M; Ozturk B; van Leenders GJ; Hall P; Czene K; Humphreys K; Liu J; Cox A; Connley D; Cramp HE; Cross SS; Balasubramanian SP; Reed MW; Dunning AM; Easton DF; Humphreys MK; Caldas C; Blows F; Driver K; Provenzano E; Lubinski J; Jakubowska A; Huzarski T; Byrski T; Cybulski C; Gorski B; Gronwald J; Brennan P; Sangrajrang S; Gaborieau V; Shen CY; Hsiung CN; Yu JC; Chen ST; Hsu GC; Hou MF; Huang CS; Anton-Culver H; Ziogas A; Pharoah PD; Garcia-Closas M
    Hum Mol Genet; 2011 Aug; 20(16):3289-303. PubMed ID: 21596841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
    Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
    J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population.
    Elematore I; Gonzalez-Hormazabal P; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G; Di Capua GA; Jara L
    Mol Biol Rep; 2014 Jun; 41(6):3715-22. PubMed ID: 24532140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
    Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
    Gao F; Ge R
    Clin Breast Cancer; 2019 Oct; 19(5):e596-e610. PubMed ID: 31324582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Genetic Variants at Nongenic Susceptibility Loci with Breast Cancer Risk and Heterogeneity by Tumor Subtype in Southern Han Chinese Women.
    Liang H; Li H; Yang X; Chen L; Zhu A; Sun M; Ye C; Li M
    Biomed Res Int; 2016; 2016():3065493. PubMed ID: 27022606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men.
    Orr N; Cooke R; Jones M; Fletcher O; Dudbridge F; Chilcott-Burns S; Tomczyk K; Broderick P; Houlston R; Ashworth A; Swerdlow A
    PLoS Genet; 2011 Sep; 7(9):e1002290. PubMed ID: 21949660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review.
    Pan W; Cheng H; Zhang J; Yang Z; Lin M
    Clin Breast Cancer; 2024 Aug; 24(6):552-561. PubMed ID: 38641470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.
    Stacey SN; Manolescu A; Sulem P; Rafnar T; Gudmundsson J; Gudjonsson SA; Masson G; Jakobsdottir M; Thorlacius S; Helgason A; Aben KK; Strobbe LJ; Albers-Akkers MT; Swinkels DW; Henderson BE; Kolonel LN; Le Marchand L; Millastre E; Andres R; Godino J; Garcia-Prats MD; Polo E; Tres A; Mouy M; Saemundsdottir J; Backman VM; Gudmundsson L; Kristjansson K; Bergthorsson JT; Kostic J; Frigge ML; Geller F; Gudbjartsson D; Sigurdsson H; Jonsdottir T; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Jonsson T; von Holst S; Werelius B; Margolin S; Lindblom A; Mayordomo JI; Haiman CA; Kiemeney LA; Johannsson OT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    Nat Genet; 2007 Jul; 39(7):865-9. PubMed ID: 17529974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2q35-rs13387042 variant and the risk of breast cancer: a case-control study.
    Nesaei A; Naderi Ghale-Noie Z; Khorshid Shamshiri A; Afzaljavan F; Rivandi M; Tajbakhsh A; Homaei Shandiz F; Pasdar A
    Mol Biol Rep; 2022 May; 49(5):3549-3557. PubMed ID: 35445312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
    Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
    Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
    Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
    Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of 8q24 rs13281615A > G polymorphism with breast cancer risk: evidence from 40,762 cases and 50,380 controls.
    Dai G; Guo Z; Yang X; Yu B; Li L
    Mol Biol Rep; 2013 Jun; 40(6):4065-73. PubMed ID: 23292077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis.
    Vrieling A; Buck K; Kaaks R; Chang-Claude J
    Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.